New York Life Investment Management LLC Myriad Genetics Inc Transaction History

New York Life Investment Management LLC

  • $9.63 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$14.51 - $20.99 $36,782 - $53,209
2,535 Added 12.69%
22,508 $326,000
Q3 2022

Nov 10, 2022
BUY
$18.21 - $27.88 $26,714 - $40,899
1,467 Added 7.93%
19,973 $381,000
Q2 2022

Aug 12, 2022
BUY
$16.45 - $25.88 $304,423 - $478,935
18,506 New
18,506 $336,000

Others Institutions Holding MYGN

# of Institutions
250
Shares Held
90.6M
Call Options Held
100K
Put Options Held
34K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.01B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email